Cancer is the most common cause of death, but the tide can be reversed by scientific cooperation on an international scale.
Since 2005 TEFAF is therefore supporting research and international collaboration by means of a special Chair of Oncology at the research institute GROW, the School for Oncology and Developmental Biology at the Maastricht University Medical Centre.

The objective of attracting visiting professors is to cement Maastricht’s oncology research with highly recognized national and international research teams, which raises cancer research and finally cancer treatment to a higher level.

Appointed as 2020 TEFAF Honorary Chair professor is Prof.Laurence Zitvogel MD, Phd. Full Professor Immunology, Biology Medical School Paris-Saclay and Scientific director of OncoImmunology Gustave Roussy.
She has been actively contributing to the field of cancer immunology and immunotherapy, bringing together basic and translational research. her expertise is mainly dendritic cell and innate effector biology and relevance during tumor development as well as exosome-based vaccine designs. She pioneered the concept of immunogenic cell death. Her team discovered the critical role and impact of gut microbiota in cancer immuno surveillance and therapies. She was recipient of many awards, including the National Academy of Medicine, the Translation Research INSERM Prize, the ASCO-SITC, the Brupbacher Awards 2017 and the ESMO Immuno-Oncology Award 2017.

Funding is necessary to ensure that researchers can continue their work. The Cancer Research Fund Limburg (Kankeronderzoeksfonds Limburg) collects money for cancer research in the Maastricht University Medical Centre.
For more information